Media Coverage
The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
-
CNN
–
Just 23% of US adults get enough exercise, CDC reports
“You can have a physically active job, but certainly, if one is out as a contractor, aspects of being a fireman or firewoman, such jobs have physical aspects to them in a way that sitting in a job do not,” said Daniel Corcos, a professor of physical therapy and human movement sciences at the Feinberg School of Medicine at Northwestern University in Chicago, who was not involved with the report. “But there are virtually no jobs out that require the heart to be elevated continuously at more than 100 beats per minute and also strengthen the muscles in a way they do in leisure-time physical activity that includes both aerobic and resistance activity.” It’s imperative for people to find ways to exercise and take ownership of their health if they want to ward off the many illnesses associated with a lack of physical activity, such as hypertension and diabetes, Corcos said.
-
HealthDay
–
Drug May Help Keep Aggressive Prostate Cancer in Check
These study results show that the drug can also be useful in containing prostate cancer that is threatening to spread beyond the prostate gland, but has not yet done so, said lead researcher Dr. Maha Hussain. She is deputy director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, in Chicago. The drug’s developers, Astellas Pharma and Pfizer, funded the new trial. They have also already asked the U.S. Food and Drug Administration to approve enzalutamide’s use in treating non-metastatic prostate cancer, Hussain said. “From a medical perspective, it can be used now,” she said. “While some patients have already been getting this drug covered by their insurance, clearly FDA approval is needed to ensure broader coverage for patients.”
-
Chicago Tribune
–
New treatment lowers risk for death from aggressive prostate cancer by over 70 percent, study finds
Some of the 165,000 U.S. men who are estimated to receive a new diagnosis of prostate cancer this year will develop resistance to hormonal therapies for the disease, but a new study by a doctor now at Northwestern Memorial Hospital points to use of an existing drug to help treat them. This kind of aggressive cancer has challenged doctors, as effective treatment to improve outcomes for these men hadn’t existed previously. But a clinical trial led by Dr. Maha Hussain, now an oncologist at Northwestern Memorial, showed that taking a drug, enzalutamide, resulted in a 71 percent lower risk of cancer spread or death, compared to those taking a placebo during the three-year trial. The patients involved all had prostate cancer that hadn’t spread but that also had not responded to hormone treatment.
-
Crain’s Chicago Business
–
Northwestern Medicine gets $25 million gift
Northwestern Medicine announced this morning that its Bluhm Cardiovascular Institute got $25 million from the Bluhm Family Charitable Foundation. Part of the gift will fund a center using “artificial intelligence and machine learning to advance the study and treatment of cardiovascular disease,” according to a statement. “I’m incredibly gratified that an increasing number of people have access to the very best care,” Neil G. Bluhm, founder and president of JMB Realty, said in the statement. “My support of Northwestern’s cardiovascular program has always been about sparking transformation and creating one of the top programs in cardiac care in the nation.” In 2005, Bluhm provided the first donation that created the Northwestern Medicine Bluhm Cardiovascular Institute. “Bluhm’s gifts have allowed us to rapidly improve our options for better and safer care for the many patients who face the life-threatening condition of heart disease,” Dr. Patrick McCarthy, the institute’s executive director, said in the statement.
-
The Wall Street Journal
–
Is Robotic Prostate Surgery Better Than Traditional Surgery?
Ashutosh Tewari, system chairman of the department of urology at Mount Sinai Health System in New York City, believes the robotic surgery is better. He regularly performs the procedure. William Catalona, professor of urology at Northwestern University’s Feinberg School of Medicine, says the open surgery, which he performs on a regular basis, remains the gold standard.
-
NBC News
–
Is chemo obsolete? Not by a long shot, cancer experts say
And, despite widespread worries about the notorious side-effects of chemo, it’s often not as bad as patients fear it will be. “I think everybody is looking for something new,” said Dr. William Gradishar, chief of the Division of Hematology/Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “Nobody is lining up to get chemotherapy if they don’t have to get it,” added Gradishar, who works with the National Comprehensive Cancer Network to help write guidelines for oncologists.
-
HealthDay
–
Psychiatric Drug Lithium Tied to Birth Defect Risk
That’s because studies have linked the drug to a heightened risk of birth defects, such as malformations affecting the heart, particularly when it’s used in the first trimester. But a “major challenge” in that kind of research is separating the effects of medication from any effects of the underlying mental health disorder, said Dr. Katherine Wisner, a perinatal psychiatrist and professor at Northwestern University in Chicago. The new study compared women who used lithium in the first trimester with women who also had bipolar disorder or depression but did not use the drug. The goal was to zero in on the effects of lithium itself.
-
Huffington Post
–
7 Weird Things That Could Be Triggering Migraines
Doctors think there are several different mechanisms behind why you might get a migraine, although “it’s not completely understood,” said Dr. Katherine S. Carroll, a neurologist and migraine expert at Northwestern Memorial Hospital in Chicago. It’s believed that there’s a wave of electricity that spread across a person’s cortex (the wrinkly, outer layer that surrounds the brain), leading to the release of inflammatory mediators, Carroll said. These irritate the nerves in the brain, including the trigeminal nerve (the largest of the cranial nerves), creating the migraine’s pain.
-
Chicago Tribune
–
Blood on the guacamole: Is avocado hand reaching epidemic proportions?
“I see it fairly frequently,” says Dr. Scott Dresden of Northwestern University’s Department of Emergency Medicine. “Patients try to stab the pit, the knife slips off the pit and they stab the hand. Or patients do a sort of hacking motion with the long blade of the knife into the pit, and hack into the webbing between the thumb and the forefinger instead. Those are two really common ways this happens. And they can be pretty nasty.”
-
U.S. News & World Report
–
Forgotten Fathers: Most new-parent programs are designed primarily for mothers, a study shows.
Clinical services may not be sensitive to men’s parenting needs. Further, mothers might limit men from being engaged in prenatal and postnatal services. Yet, men have a vital role to play during infancy. To help address the above barriers, Michael Yogman and Craig Garfield, pediatric faculty at the Harvard Medical School and Northwestern Feinberg School of Medicine, respectively, recommended that health care professionals engage in father-friendly practices. These include acknowledging fathers’ presence at health care visits, welcoming fathers directly, educating fathers about parenting and encouraging fathers to assume childcare roles early on.
